tiprankstipranks
OptiBiotix Health PLC (GB:OPTI)
LSE:OPTI

OptiBiotix Health (OPTI) Share Price & Analysis

9 Followers

OPTI Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range5.57p - 43.50p
Previous Close19.25p
Volume20.56K
Average Volume (3M)283.44K
Market Cap
£18.85M
Enterprise Value17.80M
Total Cash (Recent Filing)£1.05M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)-1.4
Beta1.61
Jun 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding91,190,661
10 Day Avg. Volume452,595
30 Day Avg. Volume283,435
Standard Deviation0.15
R-Squared0.05
Alpha0.00630
Financial Highlights & Ratios
Price to Book (P/B)2.31
Price to Sales (P/S)15328.35
Price to Cash Flow (P/CF)-15.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

43.09%0.00%0.00%56.91%
43.09% Insiders
0.00% Other Institutional Investors
56.91% Public Companies and
Individual Investors

OPTI FAQ

What was OptiBiotix Health PLC’s price range in the past 12 months?
OptiBiotix Health PLC lowest share price was 5.57p and its highest was 43.49p in the past 12 months.
    What is OptiBiotix Health PLC’s market cap?
    Currently, no data Available
    When is OptiBiotix Health PLC’s upcoming earnings report date?
    OptiBiotix Health PLC’s upcoming earnings report date is Jun 26, 2024 which is in 69 days.
      How were OptiBiotix Health PLC’s earnings last quarter?
      OptiBiotix Health PLC released its earnings results on Sep 27, 2023. The company reported -0.021p earnings per share for the quarter, missing the consensus estimate of N/A by -0.021p.
        Is OptiBiotix Health PLC overvalued?
        According to Wall Street analysts OptiBiotix Health PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does OptiBiotix Health PLC pay dividends?
          OptiBiotix Health PLC does not currently pay dividends.
          What is OptiBiotix Health PLC’s EPS estimate?
          OptiBiotix Health PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does OptiBiotix Health PLC have?
          OptiBiotix Health PLC has 97,943,160 shares outstanding.
            What happened to OptiBiotix Health PLC’s price movement after its last earnings report?
            OptiBiotix Health PLC reported an EPS of -0.021p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.273%.
              Which hedge fund is a major shareholder of OptiBiotix Health PLC?
              Currently, no hedge funds are holding shares in GB:OPTI
              ---

              Company Description

              OptiBiotix Health PLC

              OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies on researching the area of biotechnology. Its activities include identification of microbial strains which can affect human metabolism and physiology, development of microbiome modulators, natural sugars and proteins. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix and SkinBiotix.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Genedrive
              Futura Medical
              EKF Diagnostics Holdings
              ImmuPharma
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis